Edwards Lifesciences (EW) Tops Q4 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Edwards Lifesciences (EW) PT Raised to $150 at BMO Capital
February 2, 2018 8:21 AM ESTBMO Capital raised its price target on Edwards Lifesciences (NYSE: EW) to $150.00 (from $145.00) while maintaining a Outperform rating.
... MoreEdwards Lifesciences (EW) PT Raised to $174 at Canaccord Genuity
February 2, 2018 7:08 AM ESTCanaccord Genuity raised its price target on Edwards Lifesciences (NYSE: EW) to $174.00 (from $140.00) while maintaining a Buy rating. An analysis suggests the stock should trade to at least $174 by year-end, based solely on the fundamentals currently evident in the business, let alone... More
Edwards Lifesciences (EW) PT Raised to $138 at Morgan Stanley
February 2, 2018 6:55 AM ESTMorgan Stanley raised its price target on Edwards Lifesciences (NYSE: EW) to $138.00 (from $130.00) while maintaining a Overweight rating.
... MoreEdwards Lifesciences (EW) PT Raised to $155 at Barclays
February 2, 2018 4:34 AM ESTBarclays raised its price target on Edwards Lifesciences (NYSE: EW) to $155.00 (from $135.00) while maintaining a Overweight rating.
... MoreEdwards Lifesciences (EW) PT Raised to $140 at JMP Securities
February 2, 2018 4:16 AM ESTJMP Securities raised its price target on Edwards Lifesciences (NYSE: EW) to $140.00 (from $135.00) while maintaining a Market Outperform rating.
... More